Your browser doesn't support javascript.
loading
[The analysis of the hepatitis C virus infection course and efficacy of treatment dependence on HLA A antigens in children and youth]. / Analiza zwiazku przebiegu zakazenia wirusem zapalenia watroby typu C oraz skutecznosci leczenia dzieci i mlodziezy z antygenami HLA A.
Czerwionka-Szaflarska, Mieczyslawa; Los-Rycharska, Ewa; Szaflarska-Poplawska, Anna; Gronkowska, Anna; Wozniakowska-Gesicka, Teresa; Kups, Joanna; Figlerowicz, Magdalena; Liberek, Anna; Pawlowska, Joanna.
Afiliação
  • Czerwionka-Szaflarska M; Uniwersytet Mikolaja Kopernika w Toruniu, Collegium Medicum w Bydgoszczy, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii. klped@cm.umk.pl
Pol Merkur Lekarski ; 25(146): 124-31, 2008 Aug.
Article em Pl | MEDLINE | ID: mdl-18942330
UNLABELLED: The hepatitis C virus (HCV) infection course and efficacy of treatment may be depended on HLA antigens. The aim of the study is attempt to define dependence between the course of HCV infection and efficacy its treatment and HLA A antigens in children and youth. PATIENTS AND METHODS: To the study included 61 patients (51 after treatment for HCV infection and 10 not treated). The average age was 13.77 years (range 5-18 years). Patients were divided to subgroups in depend on effect of the treatment: virusological and biochemical response. Antigens HLA A were molecularly typed on the low resolution method. To statistical analysis we applied the chi-square test. RESULTS: We demonstrated no statistical significant dependences between HCV infection course and efficacy of its treatment children and youth HLA A antigens. However we observed following tendencies: antigens HLA A *01 and HLA A *02 can be related to unprofitable course of infection and unsuccessful antiviral therapy; HLA A *03 can be favorable prognostic factor for HCV infection course and response to treatment; HLA A *24 can be related to mild course of infection and profitable response to treatment; HLA A *11 can be favorable prognostic factor for course of infection; HLA A *30 can be profitable for efficacy of treatment and HLA A *25 can be disadvantage for it. Probably study performed with larger group of patients could gain dependencies statistical significant. CONCLUSIONS: It is possible that course if HCV infection and efficacy of antiviral treatment are depended on HLA A antigens.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antivirais / Antígenos HLA-A / Hepatite C Idioma: Pl Ano de publicação: 2008 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antivirais / Antígenos HLA-A / Hepatite C Idioma: Pl Ano de publicação: 2008 Tipo de documento: Article